Genmab Announces Net Sales of Darzalex for Third Quarter of 2024
15 Oct 2024 //
GLOBENEWSWIRE
Janssen`s Biologic Rybrevant (Amivantamab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Janssen Biotech`s Biologic Tremfya (Guselkumab) Receives Approval in US
11 Sep 2024 //
FDA
BigHat Collaborates on Antibody Design with ML
24 Apr 2024 //
BUSINESSWIRE